{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:02:55Z","timestamp":1791270175634,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.clineuro.2005.11.018","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T14:06:46Z","timestamp":1137679606000},"page":"327-332","source":"Crossref","is-referenced-by-count":86,"title":["Accumulation of irreversible disability in multiple sclerosis: From epidemiology to treatment"],"prefix":"10.1016","volume":"108","author":[{"given":"Christian","family":"Confavreux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vukusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2005.11.018_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","article-title":"Problems of experimental trials of therapy in MS: report by the panel on the evaluation of experimental trials of therapy in MS","volume":"122","author":"Schumacher","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clineuro.2005.11.018_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.55.8.671","article-title":"EDMUS, a European database for multiple sclerosis","volume":"55","author":"Confavreux","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/120.6.1085","article-title":"Primary progressive multiple sclerosis","volume":"120","author":"Thompson","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib6","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/brain\/114.6.2437","article-title":"The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits","volume":"114","author":"Youl","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.54.4.807","article-title":"Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI","volume":"54","author":"Fox","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00019052-200206000-00006","article-title":"Natural history of multiple sclerosis: implications for counselling and therapy","volume":"15","author":"Confavreux","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib9","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","volume":"343","author":"Confavreux","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2005.11.018_bib10","first-page":"7","article-title":"Relapses, progression, inflammation and neurodegeneration in multiple sclerosis: a changing view","volume":"2","author":"Confavreux","year":"2002","journal-title":"ACNR"},{"key":"10.1016\/j.clineuro.2005.11.018_bib11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awg081","article-title":"Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process","volume":"126","author":"Confavreux","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib12","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1212\/01.WNL.0000096175.39831.21","article-title":"Effect of relapses on development of residual deficit in multiple sclerosis","volume":"61","author":"Lublin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/brain\/103.2.281","article-title":"Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients","volume":"103","author":"Confavreux","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/brain\/112.6.1419","article-title":"The natural history of multiple sclerosis: a geographical based study. II. Predictive value of the early clinical course","volume":"112","author":"Weinshenker","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/brain\/114.2.1045","article-title":"The natural history of multiple sclerosis: a geographical based study. III. Multivariate analysis of predictive factors and models of outcome","volume":"114","author":"Weinshenker","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib16","doi-asserted-by":"crossref","first-page":"27885","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2005.11.018_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J","article-title":"Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis","volume":"47","author":"Evangelou","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-5728(00)00233-2","article-title":"The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis","volume":"107","author":"Hohlfeld","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Reingold S for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course: results of an international survey","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/brain\/122.4.625","article-title":"The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis","volume":"122","author":"Cottrel","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib21","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/brain\/122.10.1941","article-title":"The natural history of multiple sclerosis: a geographical based study. VII. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation","volume":"122","author":"Kremenchutzky","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib22","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double-blind placebo-controlled study of interferon \u03b2-1a in relapsing\/remitting multiple sclerosis","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2005.11.018_bib23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","article-title":"Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial","volume":"45","author":"Johnson","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jnnp.68.4.450","article-title":"Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts","volume":"68","author":"Liu","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib25","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/brain\/113.6.1597","article-title":"Clinical aspects of multiple sclerosis in northeast Scotland with particular reference to its course and prognosis","volume":"113","author":"Phadke","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/brain\/116.1.117","article-title":"Prognostic factors in a multiple sclerosis incidence cohort with twenty five years of follow-up","volume":"116","author":"Runmarker","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00920623","article-title":"Prediction of outcome in multiple sclerosis based on multivariate models","volume":"241","author":"Runmarker","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.58.3.300","article-title":"Multivariate analysis of predictive factors of multiple sclerosis with a validated method to assess clinical events","volume":"58","author":"Trojano","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/WNL.51.3.765","article-title":"Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG)","volume":"51","author":"Kantarci","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1191\/1352458503ms914oa","article-title":"Long-term follow-up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis","volume":"9","author":"Eriksson","year":"2003","journal-title":"Mult Scler"},{"issue":"Suppl. 1","key":"10.1016\/j.clineuro.2005.11.018_bib31","first-page":"P01.114","article-title":"Progression of disability in MS: a population-based study in Olmsted County, Minnesota","volume":"60","author":"Pittock","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib32","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archneur.56.9.1138","article-title":"Multiple sclerosis that is progressive from the time of onset. Clinical characteristics and progression of disability","volume":"56","author":"Andersson","year":"1999","journal-title":"Arch Neurol"},{"issue":"Suppl. 222","key":"10.1016\/j.clineuro.2005.11.018_bib33","first-page":"1","article-title":"Studies on disseminated sclerosis. With special reference to symptomatology, course and prognosis","volume":"133","author":"M\u00fcller","year":"1949","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.clineuro.2005.11.018_bib34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archneurpsyc.1949.02310100003001","article-title":"Prognosis in initial stage of disseminated primary demyelinating disease of central nervous system","volume":"61","author":"Thygesen","year":"1949","journal-title":"Arch Neurol Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1600-0447.1961.tb01774.x","article-title":"Lethality, duration and mortality of disseminated sclerosis in Denmark","volume":"36","author":"Hyllested","year":"1961","journal-title":"Acta Psychiatr Neurol Scand"},{"key":"10.1016\/j.clineuro.2005.11.018_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/brain\/84.2.186","article-title":"The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease","volume":"84","author":"McAlpine","year":"1961","journal-title":"Brain"},{"issue":"Suppl. 47","key":"10.1016\/j.clineuro.2005.11.018_bib37","first-page":"1","article-title":"The course of multiple sclerosis in 73 cases with computer designed curves","volume":"46","author":"Fog","year":"1970","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2005.11.018_bib38","series-title":"Multiple sclerosis: clues to its cause","author":"Leibowitz","year":"1973"},{"key":"10.1016\/j.clineuro.2005.11.018_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0404.1973.tb01320.x","article-title":"Clinical data from 418 MS patients in relation to the diagnosis. First experiences with an optical mark reader documentation system","volume":"49","author":"Poser","year":"1973","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2005.11.018_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0021-9681(77)90010-8","article-title":"Studies on the natural history of multiple sclerosis. 8. Early prognostic features of the later course of the illness","volume":"30","author":"Kurtzke","year":"1977","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.clineuro.2005.11.018_bib41","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.1982.03330070044028","article-title":"Factors associated with a malignant or benign course of multiple sclerosis","volume":"248","author":"Clark","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2005.11.018_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0404.1986.tb03531.x","article-title":"Prognostic indicators in multiple sclerosis","volume":"74","author":"Poser","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2005.11.018_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jnnp.50.5.523","article-title":"Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north-east Scotland","volume":"50","author":"Phadke","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0404.1988.tb03611.x","article-title":"Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study","volume":"78","author":"Minderhoud","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2005.11.018_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/112.1.133","article-title":"The natural history of multiple sclerosis: a geographical based study. I. Clinical course and disability","volume":"112","author":"Weinshenker","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2005.11.018_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0404.1992.tb04031.x","article-title":"Early prognostic factors for disability in multiple sclerosis, a European multicenter study","volume":"85","author":"Riise","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2005.11.018_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.58.4.417","article-title":"Prognostic factors for survival in multiple sclerosis: a longitudinal, population-based study in More and Romsdal, Norway","volume":"58","author":"Midgard","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib48","series-title":"McAlpine's Multiple Sclerosis","first-page":"191","article-title":"Natural history of multiple sclerosis","author":"Ebers","year":"1998"},{"key":"10.1016\/j.clineuro.2005.11.018_bib49","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.410390304","article-title":"The Multiple Sclerosis Collaborative Research Group (MSCRG). Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis","volume":"39","author":"Jacobs","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib51","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(98)10039-9","article-title":"Placebo-controlled multicentre randomised trial of interferon \u03b2-1b in treatment of secondary progressive multiple sclerosis","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2005.11.018_bib52","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/WNL.56.11.1496","article-title":"Randomized controlled trial of interferon-beta-1a in secondary progressive MS: clinical results","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(94)91339-0","article-title":"Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis","volume":"344","author":"Moreau","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2005.11.018_bib54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#","article-title":"Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis","volume":"46","author":"Coles","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/jnnp.62.2.112","article-title":"Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multi-center study of active disease using MRI and clinical criteria","volume":"62","author":"Edan","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jnnp.71.3.404","article-title":"Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis","volume":"71","author":"Patti","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib57","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1212\/WNL.54.5.1145","article-title":"Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group","volume":"54","author":"Rice","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib58","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/WNL.55.11.1714","article-title":"Whole brain volume changes in patients with progressive MS treated with cladribine","volume":"55","author":"Filippi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2005.11.018_bib59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-510X(00)00303-8","article-title":"The effect of cladribine on T1 \u201cblack hole\u201d changes in progressive MS","volume":"176","author":"Filippi","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clineuro.2005.11.018_bib60","first-page":"643","article-title":"Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation","volume":"75","author":"Inglese","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2005.11.018_bib61","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/rheumatology\/35.12.1263","article-title":"Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ","volume":"35","author":"Mulherin","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clineuro.2005.11.018_bib62","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","article-title":"Rheumatoid arthritis","volume":"358","author":"Lee","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2005.11.018_bib63","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0404.1982.tb03084.x","article-title":"Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from","volume":"65","author":"Patzold","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clineuro.2005.11.018_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis","volume":"339","author":"Confavreux","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2005.11.018_bib65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200102013440501","article-title":"Vaccinations and the risk of relapse in multiple sclerosis","volume":"344","author":"Confavreux","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2005.11.018_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2796.1995.tb01152.x","article-title":"Brain repair","volume":"237","author":"Compston","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.clineuro.2005.11.018_bib67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0140-6736(00)03637-0","article-title":"New cells from old","volume":"357","author":"Scolding","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2005.11.018_bib68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nature01552","article-title":"Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis","volume":"422","author":"Pluchino","year":"2003","journal-title":"Nature"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846705002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846705002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T22:29:30Z","timestamp":1547850570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846705002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0303846705002179"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2005.11.018","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}